The QualityStocks Daily Stock List
- Rare Element Resources Ltd. (REEMF)
- Karoon Energy Ltd (KRNGF)
- Coastal Carolina Bancshares, Inc. (CCNB)
- Crop Infrastructure Corp. (CRXPF)
- Exactus, Inc. (EXDI)
- Kona Gold Solutions, Inc. (KGKG)
- US Nuclear Corp. (UCLE)
- BioCardia, Inc. (BCDA)
- Beyond Commerce, Inc. (BYOC)
- Brightlane Corp. (BTLN)
- NXT Energy Solutions, Inc. (NSFDF)
- HighCom Global Security, Inc. (HCGS)
- Vilacto Bio, Inc. (VIBI)
- Sunvalley Solar, Inc. (SSOL)
Rare Element Resources Ltd. (REEMF)
TipRanks, Zacks, Investor Village, StreetWise Reports, BacktestMarket, Real Investment Advice, Dividend Investor, Junior Mining Network, Insider Financial, Stockhouse, Investing.com, Northern Miner, and MarketBeat reported previously on Rare Element Resources Ltd. (REEMF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Rare Element Resources Ltd. is a mineral resource company listed on the OTC Markets’ OTCQB. It is concentrating on delivering strategic materials to technology industries through advancing plans to develop the Bear Lodge Critical Rare Earth Project in northeast Wyoming. The Company owns a 100 percent interest in a group of 499 unpatented mining claims and 640 acres owned in patent. This mine site is roughly 12 miles northwest of the town of Sundance, Wyoming. Rare Element Resources is headquartered in Littleton, Colorado.
The Bear Lodge Project is positioned in one of the best mining districts in the world. The Project is rich in “critical rare earths” (CREE), those elements that are less common, higher valued and expected to experience better demand growth and price support over the long term.
The Company also has an option on a parcel of land situated on the outskirts of the town of Upton, Wyoming, approximately 40 miles to the southwest. This is the planned site for the Project's hydrometallurgical processing plant.
Wide-ranging geological work by Rare Element Resources since 2004, including drilling, geophysical and geochemical sampling and assaying, has resulted in a Measured & Indicated resource of 18 million tons grading 3.05 percent Total Rare Earth Oxide (TREO) at a 1.5 percent cut-off grade for the Bear Lodge Project. This includes 3.0 million tons of Measured and 15 million tons of Indicated resource.
Concerning Rare Earths at the Bear Lodge Project, the deposits there contain 10 rare earth elements. Of these, five are identified as "critical" in the Department of Energy, Critical Materials Strategy Report published in 2011. These five element plus praseodymiun, that Rare Element Resources includes because of its ability to be substituted for Neodymiun in high intensity permanent magnets, are expected to account for more than 80 percent of the Project's projected revenues.
Recently, Rare Element Resources announced additional major progress on the earlier announced third-party pilot scale testwork relating to its proprietary rare earth separation technology. The work is being conducted by Umwelt-und Ingenieurtechnik GmbH Dresden (UIT), which is an affiliate of Synchron, a significant shareholder of Rare Element Resources. The Company engaged UIT to conduct a pilot plant campaign in February of this year to verify, at pilot plant scale, all process steps from the hydrometallurgical process already validated to the final separation of Nd/Pr oxide.
Environmental baseline studies, updated last year, and the proprietary processing and separation technology confirmation, support the continuation of permitting and licensing for the Bear Lodge Project. Because of the critical nature of rare earth materials, the U.S. Department of Commerce announced on June 6, 2019, new streamlined permitting initiatives for critical minerals projects, such as Bear Lodge, that should speed up the permitting timeline.
Rare Element Resources Ltd. (REEMF), closed Monday's trading session at $0.37, up 5.4131%, on 123,702 volume with 44 trades. The average volume for the last 3 months is 372,979 and the stock's 52-week low/high is $2.97000002/$8.43999958.
Karoon Energy Ltd. (KRNGF)
HotCopper, Proactive Investors, Wallet Investor, Dividend Investor, Stockhouse, and Market Screener reported previously on Karoon Energy Ltd. (KRNGF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Karoon Energy Ltd. operates as an oil and gas exploration company in Australia, Brazil, and Peru. The Company usually looks for high equity interests in early stage exploration opportunities containing large potential targets in basins with proven Petroleum Systems. Karoon works to create shareholder value via the geotechnical work-up of the acreage, taking advantage of its high equity interests to explore and appraise these opportunities. The Company previously went by the name Karoon Gas Australia Ltd. It changed its corporate name to Karoon Energy Ltd in December of 2018. Karoon Energy is headquartered in Melbourne, Australia.
Karoon Energy’s core strategy is identifying off-shore early stage exploration opportunities. The Company’s longer-term strategy is to retain residual equity interests in the assets as they go into production.
In Australia, Karoon has a working interest (WI) in permits in three major Australian off-shore basins. Two permits, in the Browse and Carnavon Basins, are roughly 300 to 350 kilometers from the north Western Australian coastline. They encompass a combined area of 15,492 square kilometers. The third permit is in the Ceduna Basin in the Great Australian Bight. It encompasses an area of 17,793 square kilometers.
In Brazil, the Company has a WI in 6 offshore blocks in the Santos Basin. These blocks are about 200 kilometers from the coastline of the State of Santa Catarina. They encompass a combined area of roughly 720 square kilometers.
In addition, in Peru, Karoon Energy has a WI in an off-shore block in the Tumbes Basin. This block is about 10 kilometers from the north-west coast of Peru. It encompasses an area of 4,750 square kilometers.
Last week, Karoon Energy announced that its wholly owned subsidiary, Karoon Petróleo e Gás Ltda, executed a binding sale and purchase agreement to acquire a 100 percent operating interest in the Baúna field (Concession BM-S-40) in the Santos Basin, offshore Brazil for a headline consideration of US$665 million. The Baúna field comprises two producing oil reservoirs, Baúna and Piracaba that are both tied back to the leased floating production, storage, and off-loading facility (FPSO) Cidade de Itajai, and the existing undeveloped Patola discovery.
At present, this asset is producing light sweet crude at a rate of about 20 Mbopd. The expectation is that the acquisition will also deliver material operational and logistical synergies for the potential development of Karoon Energy’s existing southern Santos Basin assets, Neon and Goiá.
Karoon Energy Ltd. (KRNGF), closed Monday's trading session at $1.22, up 10.7078%, on 1,750 volume with 2 trades. The average volume for the last 3 months is 87 and the stock's 52-week low/high is $1.60699999/$7.89379978.
Coastal Carolina Bancshares, Inc. (CCNB)
StockScores, Financial Content, PR Newswire, Stockopedia, Wallet Investor, Stockhouse, Dividend Investor, Wallmine, Stockwatch, and TradingView reported previously on Coastal Carolina Bancshares, Inc. (CCNB), and we also highlight the Company, here at the QualityStocks Daily Newsletter.
Coastal Carolina Bancshares, Inc. operates as a holding company for Coastal Carolina National Bank. The Bank provides diverse banking products and services in Myrtle Beach, South Carolina. It serves individuals, businesses, and small-medium sized commercial, professional, and service companies. Incorporated in 2008, Coastal Carolina Bancshares is based in Myrtle Beach.
The community Bank serves Horry, Georgetown, Aiken, Richland, Lexington, Greenville (SC), and Brunswick (NC) counties. Coastal Carolina National Bank (CCNB) offers a complete range of deposit and lending services for small business customers and individuals. In addition, it offers full-service residential mortgage lending capabilities comprising residential first and second mortgage loans and construction loans.
Regarding Personal Banking, CCNB offers Checking Account options; Savings Accounts; Personal Loans such as Home Equity Lines of Credit; and Personal Credit Cards. For Business, the Bank offers Checking options such as Business Advantage Checking and Commercial Advantage Checking. It also offers Commercial Loans; and Savings options, including Premier Commercial Money Market, Commercial Money Market, and Certificates of Deposit. It also provides a complete line of services to meet a business’s needs. Moreover, it offers CCNB Business Credit Cards.
Furthermore, CCNB offers an assortment of mortgage options. These include Conventional Mortgages, Jumbo Mortgages/Adjustable Rate Loans, and Low-Down-Payment loans: FHA, VA Loans, USDA Loans. The Bank also offers Construction/Permanent Loans, Condotel Loans, Portfolio Loans, Bridge Loans/Short-term financing, Lot Loans, and Refinancing.
Last week, Coastal Carolina Bancshares announced Net Income of $1,125,445 or $.18 cents per diluted share for the six months ended June 30, 2019 versus $920,402 for the same period the year prior. Net Income for the three months ended June 30, 2019, was $638,547 or $.10 cents per diluted share, versus $489,874 for the same period one year ago.
Net Income for the six months ended June 30, 2019, represents a 22 percent increase and Net Income for the three months ended June 30, 2019, represents a 30 percent increase versus the same periods in 2018.
Coastal Carolina Bancshares, Inc. (CCNB), closed Monday's trading session at $8.30, up 0.606061%, on 100 volume with 1 trade. The average volume for the last 3 months is 511 and the stock's 52-week low/high is $0.230000004/$0.75.
CROP Infrastructure Corp. (CRXPF)
Pot Stock News, Daily Marijuana Observer, Morningstar, MicroSmallCap, StreetSignals, Investing News, Marijuana Stock Review, Wallet Investor, Stockhouse, TradingView, GlobeNewswire, Dividend Investor, Technical420, Stockwatch, Seeking Alpha, InvestorX, and Proactive Investors reported earlier on CROP Infrastructure Corp. (CRXPF (CRXPF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
CROP Infrastructure Corp. focuses on cannabis branding and real estate assets. The Company’s portfolio of projects includes cultivation properties in California, two in Washington State, a 1,000-acre Nevada cannabis farm, 2,115 acres of hemp CBD farms, and an increasing portfolio of common share equity in upcoming listings within the cannabis space. CROP Infrastructure lists on the OTC Markets. Incorporated in 2011, CROP Infrastructure Corp. based in Vancouver, British Columbia. The Company formerly went by the name Fortify Resources, Inc. It changed its name to Crop Infrastructure Corp. in March 2018.
The Company has developed a portfolio of assets including Canna Drink, a cannabis infused functional beverage line and 16 Cannabis brands. It works leverage strategic capital investment in land expansion opportunities; assist with key big ticket investments, including greenhouses, foundations, roads, advanced hydroponics, electrical distribution networks, and specialized lighting systems. CROP is also working to develop relationships with approved agricultural plant input partners for uniformly safe fertilizers, nutrients, herbicides, and pesticides as an element of a bulk distribution service and innovative GROWSAFE-CROPSAFE client certification program.
The Company recently announced that is Emerald Heights retail brand secured a provisional licence for a retail, delivery, and smoking lounge in Cathedral City, California, to vertically integrate its California brands. CROP’s subsidiary will be able to run delivery routes in the Bay Area, Coachella Valley, and is now seeking a Southern California distribution partner.
Last week, CROP Infrastructure announced that its first batch of THC distillate cartridges derived from the 2018 harvest have passed heavy metal and pesticide testing consistent with the excellent initial test results after the 2018 harvest. The packaging team has now resumed filling cartridges in preparation of the launch of Evolution Cannabis and Hempire brands in California. In addition, the first two greenhouses at the Humboldt organic farm have been harvested and are awaiting trimming, testing and packaging This will permit CROP to launch its premium distillate line and organic fresh flower SKUs into the California market via internal sales and the partially owned Flip Distro.
CROP Infrastructure Corp. (CRXPF), closed Monday's trading session at $0.16767, up 5.9861%, on 441,619 volume with 74 trades. The average volume for the last 3 months is 240,399 and the stock's 52-week low/high is $0.370000004/$1.25.
Exactus, Inc. (EXDI)
NetworkNewsWire, Zacks, Penny Stock Tweets, Investors Hangout, Stockopedia, Market Screener, Stockhouse, InvestorsHub, Proactive Investors, Trading View, 4-Traders, OTC Presswire, Wallet Investor, and Stockwatch reported earlier on Exactus, Inc. (EXDI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Exactus, Inc. is a healthcare company pursuing opportunities in Hemp derived Cannabidiol (CBD) products. Moreover, the Company is developing point of care diagnostics. Exactus sells its CBD products direct to consumers by way of its Hemp Healthy® brand. In addition, it sells white label products to third-party resellers. OTCQB-listed, Exactus has its headquarters in Delray Beach, Florida.
Exactus additionally engages in producing industrial hemp from farms in the State of Oregon. The Company’s plan is to extract and manufacture directly via cGMP facilities. Exactus One World is the name of the Exactus farming and production program.
Exactus intensified its efforts to lead the industry in the hemp-derived Cannabidiol (CBD) market with its initial planting of seedlings in about 200 prime acres in southwest Oregon on its Exactus One World (EOW) farms in May 2019. Exactus reported the arrival of an independent fairness opinion from Scalar, LLC highlighting EOW’s estimated enterprise value between approximately $55 million and $74 million. EOW is planting an array of genetics. It expects to yield thousands of pounds of hemp and top-quality flower per acre.
With the acquisition of Hemp Healthy, the Company’s plan is to introduce and launch additional CBD products this year. It states that Hemp Healthy will continue to serve as an information resource and leader in the CBD market place through setting the industry standards on transparency and quality with every product. The Hemp Healthy platform also offers a sales affiliate program for medical professionals and social influencers.
In January of this year, Exactus entered into a Master Product Development and Supply Agreement with Ceed2Med. Ceed2Med uses cGMP facilities and with the Agreement, Exactus has been allotted a minimum of 50 and up to 300 kilograms monthly, and up to 2,500 kilograms per year, of active phyto-cannabinoid (CBD) rich ingredients for resale. Ceed2Med is a global sourcing and distribution platform for industrial hemp and industrial hemp-derived products. Exactus offers tinctures, edibles, capsules, as well as topical solution products manufactured for use by Ceed2Med.
Earlier in July, Exactus announced that it has made substantial progress on the two 100 acre industrial hemp farms in Southwest Oregon. Farming operations are ahead of schedule. Exactus is anticipating an initial AAA Top Flower cut of greater than 20,000 pounds of multiple strains by mid September.
Following the September harvest of the top flower, Exactus is forecasting the final production per acre to surpass 2,000 pounds of dry flower biomass, yielding more than 40,000,000 mg of active cannabinoids. End consumer product SKUs (Stock Keeping Units) range from 200 mg up to 6,000 mg and average roughly 750 mg per sellable unit.
Exactus, Inc. (EXDI), closed Monday's trading session at $1.13, up 2.7273%, on 10,056 volume with 17 trades. The average volume for the last 3 months is 17,903 and the stock's 52-week low/high is $0.006095/$0.358999997.
Kona Gold Solutions, Inc. (KGKG)
Discovery Stocks, Talkmarkets, Micro Cap Daily, Trading View, Market Screener, Dividend Investor, 4-Traders, Insider Financial, Stockwatch, Stockhouse, Clay Trader, InvestorsHub, Wallet Investor, and Wallmine reported previously on Kona Gold Solutions, Inc. (KGKG), and we also report on the Company, here at the QualityStocks Daily Newsletter.
Kona Gold Solutions, Inc. is a hemp and CBD lifestyle brand centered on product development in the functional beverage sector. It has created wholly-owned subsidiaries, Kona Gold LLC, HighDrate, LLC, and Gold Leaf Distribution, LLC. Kona Gold Solutions is based in Melbourne, Florida and lists on the OTC Markets.
Subsidiary Kona Gold, LLC has developed a premium Hemp Infused Energy Drink line. The HighDrate, LLC subsidiary has developed the beverage industry’s first CBD Energy Water, available in four flavors. The Gold Leaf Distribution, LLC subsidiary was formed to fill Kona Gold Solutions’ distribution needs in markets it wants to quickly enter.
The Company’s Kona Gold Hemp Energy Drink line extension includes Bubble Gum and Candy Apple flavors. The line extension for its HighDrate CBD Energy Waters includes Blue Island Punch and Sour Apple.
Kona Gold Solutions recently announced that it launched its new Bubble Gum and Candy Apple flavored hemp energy drinks. The announcement is coming off the success of the Company’s new Cotton Candy and Cherry Vanilla flavors that went to market in late 2018 and continue to be Kona Gold’s top selling hemp energy drinks.
Last month, Kona Gold Solutions announced it partnered with 15 new distributors within the last 45 days, as of June 17, 2019. The signing of these new distribution partners places the Company’s popular Hemp Energy Drinks and CBD Energy Waters in six new States and eight States Kona Gold presently has distribution in, expanding reach and market presence in those States.
Earlier this month, Kona Gold Solutions announced it beat Q2 projected Revenue of $400,000 by more than $320,000. The Company had its first ever profitable quarter on Revenue of greater than $720,000 from sales of its popular Kona Gold Hemp Energy Drinks and HighDrate CBD Energy Waters. Kona Gold will exceed $1 million in Revenue for 2019 this month.
Last week, Kona Gold Solutions announced it expanded distribution into 4 new states, Alabama, Arizona, Iowa, and Utah where its Kona Gold Hemp Energy Drinks and HighDrate CBD Energy Waters will now sell at local retail locations. The Company has partnered with 14 new distributors within the last 30 days in 12 States across the U.S. - Alabama, Arizona, California, Florida, Indiana, Iowa, New Mexico, North Carolina, South Carolina, Texas, Utah, and Wisconsin. The Company now has distribution partners in 35 States.
Kona Gold Solutions, Inc. (KGKG), closed Monday's trading session at $0.1115, up 2.2467%, on 2,278,726 volume with 245 trades. The average volume for the last 3 months is 8,730,608 and the stock's 52-week low/high is $0.009999999/$0.041000001.
US Nuclear Corp. (UCLE)
StockPulse, Stock News Now, Market Screener, Energy Central News, Investing.com. Seeking Alpha, Stockhouse, Simply Wall St, Stockopedia, and GlobeNewswire reported earlier on US Nuclear Corp. (UCLE), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Based in Canoga Park, California, US Nuclear Corp. is a leader in radiation detection. The Company develops, manufactures, and sells radiation detection and measuring equipment globally. US Nuclear has 100 plus years of experience providing quality Chemical Radiation Detection and Monitoring Instrumentation. The Company’s shares trade on the OTC Markets Group’s OTCQB.
US Nuclear provides measurement instrumentation for the nuclear energy industry and for developing technological processes including Fusion, Thorium and Molten Salt (MSR) reactor technologies domestically and internationally. American and International customers include United States Government Agencies, the U.S. Military, Homeland Security, National Laboratories, Universities, Hospitals, nuclear reactor facilities in the U.S., China, Canada, South Korea, Argentina, Russia, as well as others. By way of three operating divisions (Technical Associates (TA)), Overhoff Technology (OTC), and Electronic Control Concepts (ECC), the Company supplies top of the line instrumentation to any industry utilizing radionuclides. These industries include nuclear power plants, national laboratories, government agencies, homeland security, military, and universities and schools. Industries also include research companies, hospitals, medical and dental centers, energy companies, weapons facilities, first responders, local governments, and manufacturing plants.
US Nuclear also involves in Product Development. The Company works closely with customers to design a system to meet their specifications. The newest product development of US Nuclear is the incorporation of radiation and chemical sensors with drone mounted platforms. The Company’s strategic partnership with FlyCFam UAV provides a complete package to a customer that flies in all-weather, heavy winds, and with a heavy payload. This provides the opportunity to fly manifold sensors at one time with real-time wireless download.
US Nuclear’s DroneRAD sales were up 777 percent in the first two quarters of 2019, over all DroneRAD sales for 2018. Based on promised new orders, sales may rise even higher. Because of new advances, Company drones are now outfitted with a complete CBRN package, chemical, biological, radiation, and nuclear sensing technology.
The DroneRAD detects radiation, such as radioactive gamma hot-spots or airborne particulates. Additionally, it is outfitted with chemical detectors and bacterial/viral collection filters. End-users for the DroneRAD include first responders, border security, military, homeland defense, NATO military, waste disposal, oil and gas, chemical plants, nuclear power plants, and many more.
Earlier this month, US Nuclear announced that it signed a strategic alliance agreement with QYSEA Technology. This agreement is to market, build, sell, and service Industrial Underwater Robot Sensor Systems in the United States and internationally. QYSEA Technology is based in Shenzhen, China. It is a world-leading manufacturer of unmanned underwater vehicles (UUV) and is known for the FIFISH, which is a professional underwater ROV for inspection, photography, videography, as well as exploration.
US Nuclear Corp. (UCLE), closed Monday's trading session at $0.998, off by 2.1569%, on 8,047 volume with 10 trades. The average volume for the last 3 months is 31,107 and the stock's 52-week low/high is $0.50999999/$0.850000023.
BioCardia, Inc. (BCDA)
StockTwits, Zacks, Insider Tracking, Street Insider, Stockopedia, Marketbeat, Capital Cube, Wallet Investor, AI Stock Finder, Dividend Investor, Barchart, and Stockhouse reported previously on BioCardia, Inc. (BCDA), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
BioCardia, Inc. is a leader in the development of comprehensive solutions for cardiovascular regenerative therapies. The Company’s biotherapeutic product candidates in clinical development are CardiAMP and CardiALLO cell therapies. A clinical-stage regenerative medicine company, BioCardia has its corporate headquarters in San Carlos, California. The Company’s shares trade on the OTC Markets Group’s OTCQB.
BioCardia also offers the Helix biotherapeutic delivery system; and the Morph vascular access product line, which provides catheter products. The Company’s lead therapeutic candidate is the investigational CardiAMP™ Cell Therapy System. It provides an autologous bone marrow derived cell therapy (using a patient's own cells) for the treatment of two clinical indications. These are heart failure that develops after a heart attack and chronic myocardial ischemia.
BioCardia’s second therapeutic candidate is the investigational CardiALLO™ Cell Therapy System. This is an allogeneic culture expanded "off the shelf" cell therapy derived from donor bone marrow cells, which have been identified to meet specified criteria. The therapy has the potential to be advanced for numerous clinical indications. This includes heart failure.
Earlier in May, BioCardia announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the AVANCE™ steerable introducer product family, designed for introducing different cardiovascular catheters into the heart. This includes through the left side of the heart via the interatrial septum.
The AVANCE steerable introducer family takes advantage of Morph “DNA” technology. This is an enhancement of BioCardia’s FDA-cleared Morph steerable introducer that adds a number of features that make the devices ideal for use in transseptal procedures and are designed to improve upon commercially-available offerings.
BioCardia also partners with other biotherapeutic companies. This is to provide its Helix systems and clinical support to their programs studying therapies for the treatment of heart failure, chronic myocardial ischemia, as well as acute myocardial infarction.
Recently, BioCardia announced positive results from a study of its Helix™ Biotherapeutic Delivery System for cell therapy used to treat patients early following acute myocardial infarction (AMI) to prevent long term heart failure. The results were presented on May 23, 2019 at EuroPCR by Christina Paitazoglou, MD, with the Cardiologicum Hamburg, Germany during a Hot Line/Late Breaking Trials session of inventive first-in-man trials and early phase studies entitled “Early transendocardial injection of autologous bone marrow-derived mononuclear cells following ischaemic myocardial events: the Alster-Helix registry.”
Dr. Paitazoglou in her presentation said, “Results suggest that intramyocardial cell therapy possibly improves left ventricular function and symptoms by attenuating myocardial remodeling on top of successful PCI and optimal standard care after AMI. Results (for the Helix™ system) are similar to the NOGA-treated patients, as previously observed in the ALSTER stem cell trial.”
BioCardia, Inc. (BCDA), closed Monday's trading session at $10.55, up 22.248%, on 4,223 volume with 22 trades. The average volume for the last 3 months is 416 and the stock's 52-week low/high is $0.094999998/$0.465000003.
Beyond Commerce, Inc. (BYOC)
Zacks, OTC Markets, Penny Stock Tweets, Stockhouse, InvestorsHub, YCharts, Street Insider, Market Screener, Wallet Investor, Simply Wall St, Financial Content, MarketWatch, Investors Hangout, Barchart, The Street, Tip Ranks, 4-Traders, GuruFocus, Stockopedia, OTC.Watch, TradingView, Morningstar, Insider Financial, and Stockinvest reported earlier on Beyond Commerce, Inc. (BYOC), and we also report on the Company, here at the QualityStocks Daily Newsletter.
Beyond Commerce, Inc. is a planned provider of B2B (Business to Business) internet marketing analytics, technologies, and related services. The Company’s planned objective is to develop, acquire, and deploy disruptive strategic software technology that will build on organic growth potential. Additionally, its planned goal is to exploit cross-selling opportunities. Beyond Commerce is based in Las Vegas, Nevada. The Company’s shares trade on the OTC Markets Group’s OTCQB.
The Company operates as a holding enterprise that focuses on “big data” companies in the global B2B Internet Marketing Analytics/Technology and Services space. Beyond Commerce plans to provide a cohesive digital product and services platform. This is to provide clients with a single point of contact for their big data, marketing and related sales initiatives. The Company’s emphasis is to develop, acquire, and also deploy disruptive strategic software technology and market-changing business models through acquisition or organic growth.
In August of 2018, Beyond Commerce announced that it was added to the LD Micro Index effective August 1, 2018. Beyond Commerce Chairman and Chief Executive Officer, Mr. George Pursglove, said at that time, "This is an exciting time for us as we continue to execute on business milestones which are translating into additional exposure in the capital markets and building on our goals for corporate transparency and credibility with stakeholders. LD Micro has championed the microcap space and I am proud that we have been included in their index and to be recognized with other successful peers in the microcap space."
Recently, Beyond Commerce announced that it signed a definitive business combination agreement with PathUX, LLC. Beyond Commerce Chairman and Chief Executive Officer, Mr. George Pursglove, said, "PathUX provides Cloud based marketing automation software and will make a great addition to our future vision, has recurring revenues and a great team. We look forward to our future growth plans together. We expect the provisions of the agreement to be implemented in the second quarter of 2019.”
Beyond Commerce, Inc. (BYOC), closed Monday's trading session at $0.0032, up 19.225%, on 2,090,984 volume with 24 trades. The average volume for the last 3 months is 4,977,912 and the stock's 52-week low/high is $0.010099999/$0.197500005.
Brightlane Corp. (BTLN)
OTC Markets, Penny Stock Tweets, Market Exclusive, TradingView, Marketwired, Simply Wall St, Stockhouse, Barchart, 4-Traders, Morningstar, GuruFocus, MarketWatch, InvestorsHub, Capital Cube, YCharts, and Infront Analytics reported earlier on Brightlane Corp. (BTLN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Brightlane Corp. is a real estate operating company listed on the OTC Markets. It provides an alternative corridor to home ownership via a right-to-purchase program after meeting certain criteria. The Company focuses on acquiring, renovating, managing, and leasing low priced single-family homes chiefly in the United States. Brightlane has its corporate headquarters in Houston, Texas. The Company has its Operations Office in Atlanta, Georgia.
Brightlane’s acquisition efforts are primarily centered in the Southeast, Midwest, and Southwest regions of the United States. Its acquisition strategy is centered on multi-family housing - serving markets that include active senior living and Class A student housing. The Company is looking to expand its service offerings by way of acquisition and property management enhancement.
Brightlane provides opportunities in the affordable housing market. This includes reasonable rents and leases. At present, the Company acquires single-family homes and portfolios of single-family homes. It pursues the acquisition of these kinds of homes via one-off purchases, the purchase of portfolios, as well as other methods of acquisition.
Brightlane is looking for growth in ancillary markets. The Company is enhancing its business plan to access higher value and higher profit market segments with synergistic effects to its business model. It is working to expand its business model into different areas. These areas include multifamily, and the above-mentioned active adult living, and student housing.
Additionally, these areas include build-to-rent in the affordable housing space, non-performing notes, as well as credit reporting. Brightlane will also execute a ground up construction platform of rental single and multifamily products.
The Company announced in June 2018 that it reinforced its plans to expand its core technology development through the exploration of acquisition opportunities to further enhance its unique property value management services. The move will help to expedite the development of Brightlane’s proprietary, cloud-based platform to simultaneously manage single family, multifamily and student housing property operations.
This past July, Brightlane announced the launch of its newly redesigned website (brightlanecorp.com) as part of a brand refresh campaign started by the Company early this year. The Company stated that the new website is well positioned as a foremost source for insights, solutions, and interactive features for the property management industry. The new site has been optimized to ensure visitors are provided a premier user experience across all digital devices.
Brightlane Corp. (BTLN), closed Monday's trading session at $0.235, up 27.027%, on 12,100 volume with 3 trades. The average volume for the last 3 months is 2,167 and the stock's 52-week low/high is $7.00/$11.50.
NXT Energy Solutions, Inc. (NSFDF)
Serious Traders, SmarTrend Newsletters, Vantage Wire, StockOoodles, and Streetwise Reports reported previously on NXT Energy Solutions, Inc. (NSFDF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
NXT Energy Solutions, Inc. is a technology business. The Company’s proprietary Stress Field Detection (SFD®) survey system uses quantum-scale sensors to detect gravity field perturbations in an airborne survey method that can be used onshore and offshore to remotely identify areas with exploration potential for traps and reservoirs. Established in 1994, NXT Energy Solutions is headquartered in Calgary, Alberta.
The Company’s unique geophysical service is for the upstream oil & gas industry. SFD® is environmentally friendly. It is unaffected by ground security issues or difficult terrain. SFD® is an airborne tool. It provides information on areas favorable to fluid entrapment in the sedimentary column. The SFD® survey is complementary to existing geophysical methods, especially seismic programs.
NXT Energy Solutions provides its clients with an effective and reliable method to lessen time, costs, and risks related to exploration. The SFD® survey system allows its clients to focus their hydrocarbon exploration decisions concerning land commitments, data acquisition expenditures, and prospect prioritization on areas with the greatest potential.
SFD®, in pre-seismic applications, can produce high-potential prospect leads in large underexplored regions. In post-seismic applications, SFD® can prioritize seismic prospects based on their reservoir potentials.
In January 2018, NXT Energy Solutions announced the first worldwide patent of the Stress Field Detection (SFD®) Technology and the development of a new generation of sensors, which will enhance the Company’s ability to provide higher quality survey results. NXT is negotiating commercial contracts for the application of its proprietary SFD® oil & gas exploration method with governments, national oil companies, and other industry participants.
Recently, NXT Energy Solutions announced its financial and operating results for the quarter-ended June 30, 2018. No survey Revenues were recorded for the first two quarters of 2018. A Net Loss of $1.96 million was recorded for the three months ended June 30, 2018. A Net Loss of $3.92 million was recorded for the six months ended June 30, 2018.
NXT Energy Solutions, Inc. (NSFDF), closed Monday's trading session at $0.39, up 30%, on 12,605 volume with 9 trades. The average volume for the last 3 months is 23,041 and the stock's 52-week low/high is $2.51999998/$6.00810003.
HighCom Global Security, Inc. (HCGS)
NetworkNewswire.com, Stockopedia, Marketwired, InvestorsHub, and 4-Traders reported on HighCom Global Security, Inc. (HCGS), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Listed on the OTCQB, HighCom Global Security, Inc. is a foremost provider of equipment and services for the security and defense industries. The Company is establishing a wide-ranging portfolio of security businesses. It acquires, manages, and builds industry leading businesses that provide specialized, mission-critical solutions, which address the needs of its customers.
The Company previously went by the name BlastGard International, Inc. It changed its name to HighCom Global Security, Inc. in August of 2014. HighCom Global Security has its head office in Columbus, Ohio.
The Company’s HighCom Armor division provides high performance and affordable body armor, personal protective equipment, as well as armor systems and related accessories. Its ballistic solutions have undergone deployment to hundreds of thousands of operators globally. This includes the U.S. armed forces, allied forces, federal government agencies, plus law enforcement and corrections, and other security personnel, domestically and internationally.
HighCom Armor Solutions, Inc. designs, develops, tests, manufacturers, and distributes body armor and personal protective equipment. This includes greater than two dozen NIJ compliant hard and soft armor products.
HighCom Global Security’s BlastGard Technologies division has patented BlastWrap® technology. This technology acts as a “virtual tent” to effectively lessen blast effects and suppress post-blast fires.
The innovative BlastWrap® technology works by triggering physical and chemical processes to dissipate blast energy. As a result, this reduces the aftermath of acoustic and shock waves, peak overpressure, reflected peak overpressure, impulse and afterburn. The remaining, considerably decreased energy is transmitted at a slower, more sustainable level.
BlastWrap® does not dispense chemical extinguishants. It uses neither alarms, sensors, nor an activation system. In addition, BlastWrap® is nontoxic and ecologically friendly.
Recently, HighCom Global Security announced that Mr. Craig Campbell, an Executive Officer and Director of the Company, submitted his resignation to the Board of Directors, effective Tuesday, January 16, 2018. Francis Michaud, who currently serves as Chief Financial Officer of the Company, was elected to the Board to fill the vacancy left by Mr. Campbell and was also appointed to serve as Chief Executive Officer (CEO).
HighCom Global Security, Inc. (HCGS), closed Monday's trading session at $0.004, off by 22.7799%, on 1,317 volume with 2 trades. The average volume for the last 3 months is 16,100 and the stock's 52-week low/high is $1.60220003/$5.20499992.
Vilacto Bio, Inc. (VIBI)
OTC Markets and The Street reported on Vilacto Bio, Inc. (VIBI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Vilacto Bio, Inc. is a biotechnology company listed on the OTCQB. It has developed the now fully patented Lactoactive® (Lactoactive molecule). In numerous studies, Lactoactive® has demonstrated above average effect treating conditions such as inflammatory diseases, diabetes, psoriasis, skin aging, and skin issues in different levels. At present the Company’s products are available on the market as Vilact®.
Founded in 2013, Vilacto Bio is headquartered in New York, New York. The Company previously went by the name Zlato, Inc. It changed its name to Vilacto Bio, Inc. on April 4, 2017. The Company’s European Headquarters are in Næstved, Denmark. Its Research and Development (R&D) operations are in Lithuania.
Vilacto Bio’s goal is to be the leading biotechnology company centered on commercializing unique pharmaceutical cosmeceutical products formulated or reformulated with Lactoactive® as nanoparticle according to its patented properties. The Company’s aim is to further develop its Lactoactive® molecule for increasing the quality of its retail and medical skin cream products, as well as licensing out its Lactoactive® molecule for the pharmaceutical industry.
Lactoactive® is highly refined colostrum, developed to provide first-rate results for people needing healing or relief from a range of skin issues. Lactoactive® is a refined processing of colostrum combined with hyaluronic acid. Proteins in Vilact® survive longer without being degraded by enzymes. This enables them to work longer in the skin.
Vilacto Bio has its Vilact Cuticle cream product, developed in cooperation with Danish podiatrists. Lactoactive, the ingredient molecule in Vilact Cuticle cream, works to help with skin challenges. Danish podiatrists have demonstrated its use with faster patient recovery.
This past January, Vilacto Bio announced that it started development of the Vilacto Bio Skincare Knowledge Center. This is an online resource that will gather skincare knowledge, science, insights and tips from scientists, dermatologists, podiatrists and other specialists around the world.
The tips and guides presented in the Vilacto Bio Knowledge Center will be shared with industry magazines internationally, and also with Vilacto customers. The expectation is that the Vilacto Bio Knowledge Center will enhance dialogue among specialists and consumers, improve outcomes, and drive higher traffic to Vilacto Bio’s commercial web portal.
Vilacto Bio, Inc. (VIBI), closed Monday's trading session at $0.0003, up 50.00%, on 10,510,597 volume with 19 trades. The average volume for the last 3 months is 71,279,232 and the stock's 52-week low/high is $0.850000023/$2.03999996.
Sunvalley Solar, Inc. (SSOL)
Wallstreetlivechat, PennyStockPros, The Stock Scout, Penny Stock Rumble, Stockhunter.us, PennyStockClub, OurHotStockPicks, PennyStocks24, Fast Moving Stocks, VIP STOCK ALERTS, and FeedBlitz reported previously on Sunvalley Solar, Inc. (SSOL), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Sunvalley Solar, Inc., by way of its subsidiary, Sunvalley Solar Tech, Inc., operates as a solar power technology and system integration company in the State of California. The Company centers on solar systems design and installation, solar technology research and development (R&D), and solar equipment manufacturing and distribution areas. Established in 2007, Sunvalley Solar is headquartered in in Walnut, California.
Sunvalley Solar acquired Rayco Energy, Inc. in 2016. Rayco Energy is an established northern California company. It specializes in providing cost-saving and efficient energy solutions to local communities and business units. This includes LED lighting, Solar Thermal, as well as Solar Electricity.
Rayco Energy combines energy efficiency measures with renewable energy sources. It services the multi-family sector (Apartments, Homeowner Associations (HOA)) and small-sized commercial projects.
Sunvalley Solar’s business development strategy is to develop the Company as the end-to-end solar energy solution provider for solar power equipment dealers, solar power system installers, and solar power energy end users.
The Company provides turnkey solar system solutions. These include designing, building, operating, monitoring, and maintaining solar power systems for owners, builders, and architecture firms. Its R&D team comprises PhDs in Optoelectronics. The team specializes in photovoltaic panel technologies (coating and focusing).
In addition, the Company’s focus is in the area of National Solar Technical Support and a Service Center. Sunvalley Solar serves small private residences and large commercial solar power users.
The Company’s R&D team’s projects include 975 kW commercial solar power systems for distribution warehouses and manufacturing companies. Furthermore, projects include 1 MW commercial solar power systems for agriculture farms and cold storage facilities.
Its R&D is presently focusing on developing new coating technology to increase the efficiency of PV panels; developing new focusing technology to reduce the size of silicon cells and reduce the silicon cost per watt; developing solar PV application technology to decrease system level cost; and developing new solar parts – Micro-inverters.
Sunvalley Solar has its patented technology – Networked Solar Panels and Related Methods. It has patented the technology "Networked Solar Panels and Related Methods" (USPTO 12/198,076). This technology enables the solar power system operator to monitor the grid status, and manage and control the output from each panel, each subsystem, and the system as a whole.
Sunvalley Solar, Inc. (SSOL), closed Monday's trading session at $0.0294, up 36.7442%, on 11,335 volume with 3 trades. The average volume for the last 3 months is 2,087 and the stock's 52-week low/high is $0.288599997/$0.446249991.
The QualityStocks Company Corner
- Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI)
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
- Trxade Group Inc. (TRXD)
- ChineseInvestors.com (CIIX)
- Grapefruit Boulevard Investments Inc. (IGNG)
- SinglePoint, Inc. (SING)
- Geyser Brands Inc. (TSX.V: GYSR)
- City View Green Holdings Inc. (CSE: CVGR)
- Sugarmade, Inc. (SGMD)
- INmune Bio Inc. (NASDAQ: INMB)
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF)
- Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
- The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)
Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI)
Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), parent company of Organigram Inc., a leading licensed producer of cannabis, recently obtained approval from Health Canada for the licensing of all of the company’s Phase 4A buildout plans, increasing its total licensed production capacity to 61,000 kg. per year (http://nnw.fm/30Wgt). To view the full article, visit: http://nnw.fm/oU6Bt.
Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint.
The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.
In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.
Significant Expansion Plans with Streamlined Licensing Process
Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.
In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.
The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.
Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.
Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products
Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.
Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.
Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.
The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.
Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.
Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.
Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.
Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.
Experienced Executive Team
- CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
- Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
- Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
- Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
- Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.
This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.
1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.
Organigram Holdings Inc. (NASDAQ: OGI), closed Monday's trading session at $5.93, up 0.508475%, on 1,576,648 volume with 5,473 trades. The average volume for the last 3 months is 1,098,178 and the stock's 52-week low/high is $0.030099999/$0.60009998.
- Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Increases Licensed Production Capacity
- Organigram Signs New Agreement for Access to 60,000kg of CBD-rich Hemp
- Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Announces Proprietary Nano-Emulsion Technology for Rapid-Onset of Cannabinoid Effects
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) was highlighted in a publication from Financialnewsmedia.com, examining how it’s no secret the cannabis market is booming globally. By 2023, The Marijuana Business Factbook projects that total retail cannabis sales in the U.S. could reach between $25 billion and $30 billion annually. In addition, according to the Brightfield Group, worldwide CBD sales are expected to soar from $591 million in 2018 to as high as $22 billion by 2022 – a compound growth rate of 147%.
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).
Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.
TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.
Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.
Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.
The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.
The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.
TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.
Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.
Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.
TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.
To learn more about the company and how to invest, contact TGOD directly at email@example.com
The Green Organic Dutchman (OTC: TGODF), closed Monday's trading session at $2.12, up 1.4354%, on 540,786 volume with 773 trades. The average volume for the last 3 months is 523,038 and the stock's 52-week low/high is $0.579999983/$1.22000002.
- Global CBD Sales Expected to Grow to $22 billion by 2022
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Upholds Commitment to Quality amid CBD Shortage
- Strong Demand for CBD Edibles to Create a $4.1 Billion Market by 2022
Trxade Group Inc. (TRXD)
Trxade Group (OTCQB: TRXD), an integrated pharmaceutical services company, today announced the company’s financial results for its second quarter, ended June 30, 2019, as well as provided a business update and positive outlook for the rest of 2019. To view the full press release, visit: http://nnw.fm/4Vk5S.
Trxade Group Inc. (TRXD) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.
Trxade will leverage and scale its fully integrated model to execute the following growth strategies:
- Increase share of pharmacist drug purchasing
- Additional SKUs and expand product breath
- Partner with Specialty and International Mfg.
- Expand mail order licenses to all 50 states
- Scale Delivmeds for consumer delivery nationwide
- Integration with telemedicine
- M&A Opportunities within drug value chain
Founded in 2010 and headquartered in Tampa, Florida, Trxade's overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company's pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.
The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.
Trxade targets these independent pharmacies, leveraging a robust, "E-Bay/Kayak-like" technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.
Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!
Trxade also targets the "consumer side" of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.
The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called "Delivmeds" (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.
Trxade's Managed Services Organization ("TrxadeMSO") enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.
These offerings ensure the best-suited pharmacy receives the patient's information, thereby ensuring appropriate medication coverage based on the patient's location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.
Health Care Market
The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.
Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.
Trxade's fair online market platform targets the nation's retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.
TRxADE's programs include:
- TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.
- RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks ("PAC") to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry.
- Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE's advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process.
Trxade's management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.
Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary
Suren Ajjarapu has served as Trxade's chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.
Prashant Patel – Director, President and Chief Operating Officer
Prashant Patel has served as Trxade's full-time president and COO, and as a director since the company's acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.
Trxade Group Inc. (TRXD), closed Monday's trading session at $0.60, up 11.3173%, on 10,000 volume with 2 trades. The average volume for the last 3 months is 2,338 and the stock's 52-week low/high is $6.38181877/$8.45454597.
- Trxade Group Inc. (TRXD) Reports Record Revenues, Increased Gross Profit and Operating Income in Q2 2019
- Trxade Group Inc.’s (TRXD) Web Platform Protects Profit Margins, Cuts Negative Reimbursement Costs
- Trxade Group Inc. (TRXD) Building Reputation of Transparency in Effort to Improve on Pharmaceutical Supply Chain Concerns
ChineseInvestors.com, Inc. (OTCQB: CIIX), an established financial news and investment portal for the global Chinese-speaking community, announced today that a replay of its July 24 investor webinar is now available. The webinar features a presentation by CEO Warren Wang who discusses recent achievements and upcoming milestones related to the company's expanding CBD business. To watch the webinar and Q&A session, please visit: https://youtu.be/4N9AsvDL-Ig.
Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.
Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.
At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.
CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.
The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.
Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.
In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.
ChineseInvestors.com (CIIX), closed Monday's trading session at $0.42, up 7.6923%, on 89,856 volume with 37 trades. The average volume for the last 3 months is 41,258 and the stock's 52-week low/high is $0.119900003/$0.529999971.
- ChineseInvestors.com Investor Webinar Replay Now Available
- 420 with CNW – NYC Council Passes Two Cannabis Reform Resolutions
- ChineseInvestors.com Inc. (CIIX) Provides Premier Market Data Via Unique Website
Grapefruit Boulevard Investments Inc. (IGNG)
Imaging3, Inc./Grapefruit (OTCQB:IGNG), (“Grapefruit” or the “Company”) announces that on Friday July 26, 2019 the Company filed a registration statement on Form S-1 with the SEC to register shares of the Company’s common stock underlying the $600,000.00 convertible note recently issued by the Company to an institutional investor (the “Investor”), as well as other securities to be issued to the Investor. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. A bipartisan bill introduced in the U.S. Senate on Monday seeks to ensure greater access to insurance policies for marijuana businesses in states where the drug is legal. The bill titled “Clarifying Law Around Insurance of Marijuana (CLAIM) Act” was sponsored by Sen. Bob Menendez (D-NJ). The cosponsors of the legislation are Sens. Jeff Merkley (D-OR), Rand Paul (R-KY) and Kevin Cramer (R-ND).
Grapefruit Boulevard Investments Inc., a California corporation (“Grapefruit”), as of May 31, 2019, is a wholly owned subsidiary of Imaging3 Inc. (OTC: IGNG), a Delaware corporation whose shares of $.001 par value common stock are publicly traded on the OTCMarkets OTCQB Market under the symbol “IGNG.” IGNG is subject to the reporting requirements of the Securities Exchange Act of 1934 and files annual and quarterly reports pursuant thereto. Grapefruit holds licenses originally issued by the State of California in January 2018 to both manufacture and distribute cannabis products. Grapefruit’s management now owns a controlling interest in IGNG which now owns 100% of Grapefruit’s outstanding shares. As a result, IGNG’s financial reports will consolidate both IGNG’s and Grapefruit’s balance sheet, statement of operation and statement of cash flows and IGNG and Grapefruit will be operated as a single company. IGNG intends to change its name to Grapefruit and to obtain a more appropriate trading symbol as soon as possible. Hereinafter the combined companies will be referred to as “Grapefruit” or the “Company.”
Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds licenses to both manufacture and distribute cannabis products which were originally issued in January 2018 and is fully compliant with all applicable laws and regulations to operate its cannabis manufacturing and distribution businesses.
The company is well-focused on sourcing only the “best of the best” raw cannabis materials to create the highest quality, most-trusted and consistent recreational and medical cannabis products for its customers. Grapefruit is committed to ensuring class-leading quality by rigorously testing the purity and potency of its raw materials throughout the manufacturing process and distribution chain.
Grapefruit owns and operates its fully licensed and compliant ethanol extraction laboratory located in the Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, California. The company’s extraction lab produces high quality, cannabis-derived distillate, also known as “honey oil,” from cannabis flower and “trim.” THC honey oil is one of base cannabis commodities which serves as the active ingredient in everything from infused edibles and tinctures/creams to the cartridges used in vapes and e-cigarettes. Honey oil often sells on the wholesale marketplace for thousands of dollars per liter, with pricing being dependent on quantity purchased, as well as other market factors such as the availability and cost of the underlying flowers and/or trim.
Grapefruit began its extraction operations in May 2019. Plans are in place to expand its honey oil production through the purchase of additional distillation equipment, which is expected to significantly increase the company’s production capacity by the fourth quarter of 2019. Grapefruit’s extraction lab is fully scalable and expansion will be built-out on a two-acre lot owned by Grapefruit at the Coachillin’ site adjacent to its current manufacturing and distribution operation.
Grapefruit selected the City of Desert Hot Springs for its cannabis extraction laboratory, because the city has created a friendly business environment for cannabis-based manufacturers, including incentives like the absence of taxes on cannabis oil production revenues. This affords Grapefruit a fundamental competitive market advantage over other Honey Oil producers.
The California cannabis regulatory scheme is unique in that it requires all cultivators (cannabis farms) and manufacturers (whether producing oils/distillates, infused edibles, tinctures creams or other cannabis products) to sell their products into the legal cannabis wholesale and retail markets exclusively through licensed distributors such as Grapefruit. Grapefruit initially obtained its California recreational and medicinal cannabis distribution license Jan. 4, 2018. In May 2019, Grapefruit was granted its provisional distribution license which is renewable annually, thereby cementing the regulatory foundation necessary to rapidly expand its distribution business.
Grapefruit’s distribution license affords it a twofold strategic advantage: first, to market and sell its own cannabis product lines to retailers throughout California; and second, to buy and resell bulk cannabis flowers and trim as well as all other legal cannabis products to properly licensed distributors and/or retailers throughout California.
The Coachillin’ Canna-Business Park, home to Grapefruit’s current operating facilities and adjacent two-acre parcel of land, is a 160-acre, self-contained legally mapped compound providing the Company with a fully permitted and serviced physical plant from which Grapefruit intends to establish a leading position in the booming California cannabis sector. The parcel was purchased by the Company prior to the Park’s full development, and the value of the land the Company owns has conservatively since doubled in value to over $2 million. Additional long-term benefits of the Coachillin’ compound include agricultural rates for power, which are currently $0.09 per kilowatt hour; the Park’s deep-water well that fully satisfies its need for water; and security expenses shared by all resident businesses. The Coachillin’ Park’s promoters also plan to position the Park, located only 10 miles north of rapidly growing uptown Palm Springs and less than 15 miles from the site of the Coachella and Stagecoach music festivals as a must-see canna-tourism destination.
Grapefruit’s ultimate goal is to become a vertically integrated, seed-to-sale cannabis and CBD product company serving the California market. Moreover, it plans to roll-out its product lines in other states, such as Nevada, Illinois, Oregon, Colorado and Washington. Grapefruit has plans to build a large, all-inclusive facility that will house a 50,000-square-foot-plus indoor grow canopy, a large extraction laboratory designed to extract both THC and CBD cannabinoids via non-volatile (ethanol) and volatile (butane) processes, a manufacturing space to produce Grapefruit’s vape lines and CBD products, an FDA-certified kitchen for the production of Grapefruit edibles and a distribution facility to sell all products into the entire cannabis market. The indoor grow canopy operation will be outfitted and operated to produce ultra-high-quality flowers and buds, some of which, along with the high-quality trim resulting from cleaning and maintaining the grow, will provide biomass necessary to feed the company’s extraction laboratory. Fueled by this hand cultivated biomass, Grapefruit’s lab will continuously produce pesticide and heavy metal-free world class honey oil to both serve as the active ingredient in all of Grapefruit’s branded and unbranded products and meet the projected ever-growing demand for high quality honey oil in the California market.
Grapefruit’s motto – A High You Can Trust – embodies its philosophy and ethos, reminding consumers of the company’s commitment to manufacturing, procuring and distributing only the highest quality all-natural cannabis flower, concentrates and related products that are free from pesticides, heavy metals and bacteria. Grapefruit will target its products to all recreational cannabis enthusiasts’ as continuous, consistent cannabis products. By relentlessly adhering to these policies Grapefruit intends to become the Titleist of the Cannabis industry, known for unwavering quality and consistency.
Grapefruit is managed by a team of experts possessing the experience, skill and resources required to succeed in the competitive cannabis marketplace. Founded by brothers Bradley Yourist, CEO, and Daniel Yourist, COO, Grapefruit has expanded to become a group of industry professionals sharing a passion for all things cannabis. Both the CEO & COO are attorneys licensed to practice law the State of California who possess expert cannabis licensing and regulatory expertise and experience, which will allow Grapefruit to deftly navigate the ever changing California regulatory landscape and apply for new cannabis licenses at reduced costs when necessary, rather than having to acquire licenses that are often overvalued and/or pay outside counsel to handle such matters.
Grapefruit also has its own line of cannabis-infused concentrates and edibles. Among the brands now in stores or soon to be launched are:
- Rainbow Dreams is a new lifestyle brand designed specifically for the recreational cannabis marketplace. The Rainbow Dreams brand captures the anything goes party vibe of the 1970s by offering an array of cannabis products, such as a line of vape carts with unique cannabis strains combined with all-natural flavors for a superior no-burn experience. Rainbow Dreams fills an important niche in the marketplace as a top shelf quality product line that is competitively priced.
- Sugar Stoned, which Grapefruit acquired in the winter of 2018, has always been a popular cannabis edibles brand which terminated operations when recreational cannabis became legal and required a license in California. Grapefruit purchased the Sugar Stoned brand in 2019 and it is now a Grapefruit portfolio brand consisting of a premium quality cannabis-infused gummy line with eight different flavors: blue raspberry, cherry, grape, peach, pineapple, sour apple, strawberry and watermelon. Grapefruit intends to expand the brand in the near future through the release of a variety of infused cookies.
Grapefruit Boulevard Investments Inc. (IGNG), closed Monday's trading session at $0.085, up 6.851%, on 21,255 volume with 8 trades. The average volume for the last 3 months is 173,963 and the stock's 52-week low/high is $0.048/$4.00.
- Imaging3, Inc./Grapefruit Announces Filing of Registration Statement
- 420 with CNW – Bipartisan Senate Bill Seeks to Ease Marijuana Business Access to Insurance Services
- NetworkNewsBreaks – Why Grapefruit Boulevard Investments Inc. (IGNG) Is ‘One to Watch’
SinglePoint, Inc. (SING)
SinglePoint Inc. (OTCQB: SING) provides shareholder update on key company initiatives. SinglePoints most recent acquisition, Direct Solar, has been a major success having the largest weekend in contracts closed to date. Direct Solar is fundamentally changing SinglePoint’s underlying structure and building a solid financial base for the company to continue growth and acquisitions. Direct Solar has exceeded expectations, growing quickly and providing opportunities such as commercial solar applications and renewable energy financing options. Also today, NetworkNewsWire released a report on the company detailing how what started as a full-service, mobile-technology provider has grown into a recognized brand with multiple revenue streams. A recent acquisition in alternative energy has exceeded the company’s expectations, and growth is abundant across all of the company’s revenue streams.
SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.
SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.
SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:
- A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
- A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
- A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
- Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
- Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
- Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.
SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.
Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.
SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.
SinglePoint, Inc. (SING), closed Monday's trading session at $0.0145, up 2.5605%, on 2,471,206 volume with 96 trades. The average volume for the last 3 months is 6,105,933 and the stock's 52-week low/high is $0.007199999/$0.149399995.
- Shareholder Update Overviewing Key Growth Initiatives: Solar, Hemp, and Merchant Services
- SinglePoint Inc. (SING) Sees Growth Across Multiple Revenue Streams
- SinglePoint, Inc. (SING) CEO Discusses Acquisition Sales Success, CBD Business and Merchant Services Progress on MoneyTV with Donald Baillargeon
Geyser Brands Inc. (TSX.V: GYSR)
Geyser Brands (TSX.V: GYSR) this morning announced its post-RTO audited financial statements ("Annual Financial Statement") for the 8-months ended March 31, 2019, as well as accompanying management discussion and analysis. According to the update, the Annual Financial Statement represents Geyser’s transitional fiscal year following its RTO and change in the fiscal year end, which is further described in the Notice of Change in Corporate Structure filed on the company's SEDAR profile. To view the full press release, visit: http://nnw.fm/FNi7e.
Geyser Brands Inc. (TSX.V: GYSR) is a consumer healthcare company that builds and markets some of the world's most loved cannabis products and brands in the nutraceutical, cosmetics, food and beverage and pet sectors. Using its proprietary nanotechnology formulation, the company delivers creams, beverages, baked goods and tincture formulations with superior bioavailability and water solubility.
The efficacy of most hemp?products is restricted as the insoluble nature of the molecules prevents most of the product from permeating the skin or entering the body system. Geyser Brands solves this insolubility problem with an advanced delivery system that quickly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency.
Made with all-natural materials, NanoFusion technology offers an array of advantages: enhances penetration for deeper skin penetration; improves the transport of active ingredients for site-specific targeting; delivers active ingredients across cell membranes for release within the cell; provides longer shelf-life and stability of molecules.
Geyser Brands operates a 7,000-square-foot facility in Port Coquitlam, British Columbia, where its initial cannabis cultivation generated the first revenues out of the company's cultivation license granted in October 2018. Geyser Brands is approved as a licensed producer in compliance with Health Canada standards, which allows the company to pursue its processing and sales license. Obtaining this license will enable the company to extend its products and brands into the regulated Canadian cannabis market and directly to the consumer medical market.
Geyser Brands's integrated production chain and formulation lab develops innovative products using high-quality hemp and CBD for healthy lifestyle brands while its R&D lab produces product formulations designed to enhance bio-availability of hemp and CBD and shelf stability while maintaining all-natural ingredients and ensuring premium quality.
Geyser Brands will continue to seek opportunities to invest into the research and development of unique high-quality proprietary strains and technologies that target specific health-related conditions such as pain and inflammation reduction, insomnia, digestive issues and other commonly known ailments.
Among the brand formulations in Geyser Brand's portfolio are:
- Apothecary all-natural Hemp Terpene Pain Cream with optimal skin permeation
- Prohibition Cold Brew Mocha designed with water soluble hemp molecules
- Apothecary health products created to deliver fast-acting and high bioavailability in a spray formulation
- Baked hemp infused pet products, designed to alleviate anxiety and pain, created with NanoFusion for dosage control
Since 2014, Geyser Brands' CEO and Co-Founder Andreas Thatcher has been a principal at Rhizome Group, an entertainment company focused on building media IP through creative and market development. He previously was a founding partner at Rhizome Capital LLC, a U.S.-based media?investment?company specializing in marketing and distribution financing, and worked in the Investment Banking industry in?London and Toronto. Thatcher holds a master's degree in economics.
CFO Barry McKnight obtained his bachelor's degree from the University of British Columbia and is a Chartered Professional Accountant and?Certified Management Accountant registered in British Columbia. McKnight has over 20 years of experience as the principal of Barry D. McKnight Inc. He formerly was also a director of Indigo Sky Capital Corp. and has been the CFO and a director of the Company since 2016 and Corporate?Secretary of the Company since 2017.
Geyser Brands's Co-Founder Brad Kersch brings a strong business background with over 20 years of experience in?successful startups and working?with Fortune 500 companies. He spent his early years in the advertising and?marketing field and went on to form Hyperware, a clothing?company that sold branded clothing to retailers across Canada?before selling to clothing giant Ocean Pacific (OP). Kersch?became the president of Shoreline Studios, Canada's largest and?oldest?studio for film and TV. In 2014 he started Solace Management Group, a hemp product company focused on pet, cosmeceutical, and nutraceutical markets. As of February 2019, Geyser Brands signed a non-binding LOI to acquire Solace Management. Upon completing the proposed Solace acquisition, Geyser Brands intends to launch into the execution phase of its plan — to take its brands global through retail and digital direct-to-consumer experiences, launching its hemp-infused cannabis brands and products in the U.S., European Union, and Asia, and its CBD-infused line of products in jurisdictions where the therapeutic ingredient is legal.
Kuldip Gill, head of Geyser Brands' R&D program, has more than 35 years of experience in the cannabis industry. Gill built the largest manufacturing facility?in the lower mainland in Surrey, British Columbia, complete with R&D, analytical and quality control labs approved by both the FDA and Health Canada. He has to date created over 3,500 formulas, most notably Lakota pain relief gel. Gill's experience and proven track record is evident in the strongly marketable formulations he has developed and sold worldwide.
Geyser Brands Inc. (TSX.V: GYSR), closed Monday's trading session at $0.53, even for the day, on 500 volume. The average volume for the last 3 months is 6,018 and the stock's 52-week low/high is $0.202000007/$2.8499999.
- Geyser Brands Inc. (TSX.V: GYSR) Releases Post-RTO Financial Results for the 8-months ended March 31, 2019
- NetworkNewsBreaks – Geyser Brands Inc. (TSX.V: GYSR) Appoints Seasoned Life Sciences Executive to Board of Directors
- Geyser Brands Inc. (TSX.V: GYSR) Strengthens Leadership with Key Appointments
City View Green Holdings Inc. (CSE: CVGR)
City View Green Holdings Inc. (CSE: CVGR), a vertically integrated cannabis company focused on seed to retail, is creating a diversified company that investors can appreciate. City View has successfully attracted top talent in a time when competition is fierce among firms looking to solidify their positions in the quickly growing cannabis marketplace.
City View Green Holdings Inc.'s (CSE: CVGR) (formerly Icon Exploration Inc.) primary objective is to create a well-diversified company focused on assessing and potentially acquiring targets in the cannabis industry. Icon Exploration recently signed a formal share exchange agreement relating to its proposed acquisition of privately held City View Green (“CVG”), a vertically integrated cannabis company incorporated under the laws of Ontario, Canada. CVG’s application to Health Canada for an A6ccess to Cannabis for Medical Purposes Regulations (“ACMPR”) license is now at the in-depth review stage of the licensing process.
CVG is preparing a 40,000-square-foot growing facility near Toronto to produce pharmaceutical-grade cannabis once its ACMPR license is granted. About half of the facility will initially be outfitted with state-of-the-art LED lighting, HVAC and dehumidification systems, and automation technologies to optimize the quality, safety and consistency of cannabis production. About 4,000 square feet will be devoted to an extraction laboratory featuring an ultra-efficient CO2 supercritical extraction process with plans to include ethanol extraction technology in the future.
Another 4.3 acres remains available for future construction of up to 125,000 square feet of grow and extraction space. Production plans include producing high quality edible products, distillates, and water-soluble products for the rapidly expanding CBD-infused (cannabidiol) beverage market.
Icon and CVG have assembled a talented team that includes a Master Grower with cannabis-industry experience to manage indoor grow operations and an extraction expert whose expertise in developing and launching new products was honed while working in Washington state’s cannabis sector. Having gained experience in the Washington state market the extraction expert has a number of brand ideas and recreational cannabis products that became popular in the Washington market as well as a number of in-licensing branding opportunities available to CVG. CVG has also negotiated an agreement with a private company seeking 37 retail cannabis licenses in Alberta, Canada, that provides a reciprocal exchange of shares, product, shelf space and distribution lines. Early discussions with various entities in Europe to arrange an off-take agreement for CBD oils and extracts are also underway.
The Canadian medical cannabis market has steadily been growing with an average 10 percent increase in patients each month. Now that the Canadian federal government has legalized recreational cannabis for adult users nationwide, analysts project a compound annual growth rate of nearly 78 percent from 2018 to 2021, reaching an estimated $3 billion by 2021, ArcView Market Research reports. One study from Deloitte pegged the potential economic impact of legalized medical and recreational marijuana in Canada – including transportation, licensing fees and security – at more than $22 billion over the coming years. Health Canada’s most recent data show that sales of cannabis extracts grew 961 percent in the second quarter of 2017, compared to an 89 percent increase in growth of dried cannabis during the same period.
City View Green Holdings Inc. (CSE: CVGR), closed Monday's trading session at $0.125, even for the day. The average volume for the last 3 months is 123,002 and the stock's 52-week low/high is $7.30000019/$14.6999998.
- City View Green Holdings Inc. (CSE: CVGR) to Build Retail Footprint, Adds Depth to Green Team
- City View Green Holdings Inc. (CSE: CVGR) Reports Debt Settlements, Further Transactions
- City View Green Announces Debt Settlements and Other Transaction
Sugarmade, Inc. (SGMD)
Hydroponics supply company Sugarmade (OTCQB: SGMD) is utilizing its expertise to expand across market sectors and seize various opportunities as they arise. An article discussing the company reads, “Utilizing a narrowband Internet of Things (NB-IoT) technology, the company has created an AI-based hemp cultivation and agricultural monitoring system. To view the full article, visit: http://nnw.fm/YV1Rl.
Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.
Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.
Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.
Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.
Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.
Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.
Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.
CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.
Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.
Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6
Sugarmade, Inc. (SGMD), closed Monday's trading session at $0.014, even for the day, on 8,357,860 volume with 239 trades. The average volume for the last 3 months is 3,028,700 and the stock's 52-week low/high is $0.0017/$0.100000001.
- Sugarmade Inc. (SGMD) Leveraging Hydroponic Expertise to Target Rapidly Expanding Markets
- Sugarmade Announces Initial Investment in Hempistry and Completion of BZRTH Audit
- 420 with CNW – Second Marijuana Home Delivery Lawsuit Filed in California
INmune Bio Inc. (NASDAQ: INMB)
The battle to marshal naturally occurring cells within the human body to destroy cancerous tumors has gained new intelligence that appears to strengthen an immunotherapy strategy employed by clinical-stage biotechnology company INmune Bio Inc. (NASDAQ: INMB). The encouraging report arises from research on tumor-primed vs. cytokine-primed human natural killer (NK) cells, published in June in peer-reviewed, open-access scientific journal PLOS ONE (http://nnw.fm/5yNeD).
INmune Bio Inc. (NASDAQ: INMB) is a diversified clinical-stage immunology company developing novel therapies that target distinct parts of a patient's innate immune system to fight disease. Drug candidates INKmune™ and INB03 may be used to treat cancer while XPro1595 targets neuroinflammation as a cause of Alzheimer's disease. INmune Bio's product platforms utilize a precision therapy approach to promote the body's innate immune response to treat unsolved problems in medicine.
INmune Bio is the first biotechnology company to close an initial public offering (IPO) in 2019 and commence trading on The Nasdaq Capital Market. The company also received a "Part the Cloud" award from the Alzheimer's Association in 2018 which included a $1 million grant to advance INmune Bio's XPro1595 drug candidate.
INmune Bio's product pipeline targets three segments of concern:
- Alzheimer's disease/dementia claims 5.5 million patients in the United States. INmune Bio views Alzheimer's as an immunologic disease which changes the drug discovery process, changes the way clinical trials are designed, and may provide hope for patients and caregivers.
- Cancer residual disease which is expected to generate more than 1.7 million new cases yearly with an estimated 609,640 fatalities. INMB believe that converting resting Natural Killer ("NK") cells to primed NK cells, which kill cancerous cells on contact, is an important therapeutic strategy to help clear residual disease.
- Resistance to immunotherapy. By preventing the proliferation and function of cells that resist immunotherapy, patients should have a stronger immune response to cancer cells and may respond better to other cancer treatments including immunotherapy and live longer.
INmune Bio Drug Candidates and Clinical Programs
INKmune is a biologic delivery system that primes a patient's resting NK cells to kill cancer. INKmune targets residual disease for patients that have completed initial cancer therapy (surgery, radiation and/or chemotherapy) and have a low burden of disease with a high risk of relapse.
In late 2019, INKmune will start enrolling patients in a phase I/II trial for women with relapsed refractory ovarian cancer. In many patients, cancer relapse after seemingly effective cancer therapy is due to a failure of the patients own NK cells to eliminate minimal residual disease ("MRD").
Using a novel mechanism of action and a precision medicine approach, INKmune therapy should enhance NK cells' ability to eliminate residual disease.
INB03 is a checkpoint inhibitor that targets myeloid derived suppressor cells ("MDSC") which can produce an immunosuppressive shield that prevents a patient's own immune system from attacking the cancer. INmune Bio is currently completing a monotherapy INB03 phase I trial in patients with advanced solid tumors. The INB03 program will transition into a combination therapy clinical program in the summer of 2019 to prepare for a phase II trial in patients resistant to checkpoint inhibitors due to increased MDSC.
Treatment with INB03 should eliminate MDSC in the tumor microenvironment to allow checkpoint inhibitors to be therapeutically effective.
XPro1595 targets the microglial immune cells of the brain that are activated in many Alzheimer's disease patients. These microglial cells are a cause of neuroinflammation that can kill nerve cells and promote synaptic dysfunction – the cause of dementia in Alzheimer's.
The three-month, phase I trial is expected to enroll 18 patients in summer of 2019. It is designed to measure traditional and novel biomarkers of inflammation in patients with mild to moderate Alzheimer's disease who have neuroinflammation. The trial is supported by a $1 million "Part the Cloud" grant from the Alzheimer's Association. Inflammation, especially chronic inflammation, is being recognized as an important part of the pathology of many diseases including cancer and Alzheimer's disease.
Dr. RJ Tesi, M.D., INmune Bio co-founder, CEO and acting chief medical officer, has been a licensed physician since 1982 and a Fellow of the American College of Surgery since 1991. He received his medical degree from Washington University School of Medicine in 1982 and has served many roles in several development-stage biotech companies focused on treatment of neurodegenerative diseases, hematologic malignancies, and other inflammatory diseases.
CFO David J. Moss co-founder, has been with the company since its formation in September 2015. He holds an MBA from Rice University and a bachelor's degree in economics from the University of California, San Diego. Moss has founded, funded and taken public various companies in a variety of industries since 1995.
Mark Lowdell, Ph.D. co-founder, has served as the chief scientific officer and chief manufacturing officer at INmune Bio since the company's formation. He is a professor of cell and tissue therapy at University College London where he has led a translational immunotherapy group since 1994. He has also been a director of cellular therapy at the Royal Free London NHS Foundation Trust. He received his Ph.D. in clinical immunology from London Hospital Medical College, University of London in 1992 and is a qualified immunopathologist.
Christopher J. Barnum is director of neuroscience at INmune Bio. Barnum is a neuroimmunologist with broad expertise across neurodegenerative and psychiatric diseases holding multiple positions in academic and industry. His focus has been on translating inflammatory therapies into clinical treatments for neurologic diseases using a biomarker-directed approach. Barnum's research has been supported by the NIH, the Michael J. Fox Foundation, and the Alzheimer's Association. He received his Ph.D. in neuroscience from Binghamton University.
INmune Bio Inc. (OTC: INMB), closed Monday's trading session at $9.00, off by 2.3861%, on 11,920 volume with 78 trades. The average volume for the last 3 months is 12,519 and the stock's 52-week low/high is $0.039999999/$0.75.
- Research Highlights Virtues of INmune Bio Inc.’s (NASDAQ: INMB) Strategy in Fighting Cancer with Body’s Own Natural Cells
- INmune Bio Co-Founder and CEO Presents at 17th Annual Congress of International Drug Discovery Science & Technology 2019
- NetworkNewsBreaks – INmune Bio Inc.’s (NASDAQ: INMB) Innovative Drug Candidate Targets Neuroinflammation to Treat Alzheimer’s Disease
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)
Plus Products (CSE: PLUS) (OTCQX: PLPRF) recently announced the listing of its debentures and warrants from its brokered private placement on the Canadian Securities Exchange under ticker symbols ‘PLUS.DB’ and ‘PLUS.WT’ on July 2, 2019 (http://nnw.fm/h6aRG). To view the full article, visit: http://nnw.fm/QJTx8.
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.
First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.
PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.
Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.
During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:
- Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
- Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
- Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
- Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
- Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
- Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.
“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”
The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.
Plus Products Inc. (PLPRF), closed Monday's trading session at $2.8762, up 0.216028%, on 54,956 volume with 84 trades. The average volume for the last 3 months is 56,967 and the stock's 52-week low/high is $0.150000005/$0.689999997.
- Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Gains Approval for Listing of Debentures, Warrants on the CSE
- Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Debuts New Look for Cannabis Line
- PLUS Products Kicks off Advertising Campaign Across California
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
Green Growth Brands, Inc. (CSE: GGB) (OTCQB: GGBXF) ("GGB" or "the Company") today announced that it has executed an amendment (the "Amendment") to the Share Purchase Agreement (the "Agreement"), dated June 3, 2019, with Spring Oaks Greenhouses, Inc. ("Spring Oaks"), pursuant to which GGB is to acquire all of the issued and outstanding shares of capital stock of Spring Oaks. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. Just as skeptics were beginning to grudgingly acknowledge that marijuana’s cannabinoids do have medical benefits, a new wave or revolution is about to start if new research into the painkilling effects of the flavonoids unique to cannabis is anything to go by. A team of Canadian researchers has found that two flavonoids found in cannabis could be 30 times more powerful than aspirin, without the adverse effects associated with the conventional painkiller.
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.
In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.
Products under the Green Growth Brand umbrella include:
- CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
- Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
- Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
- Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
- The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
- XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.
Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.
Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.
Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.
Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.
CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.
CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.
Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.
Green Growth Brands Inc. (OTCQB: GGBXF), closed Monday's trading session at $1.6954, off by 2.9814%, on 342,728 volume with 490 trades. The average volume for the last 3 months is 419,173 and the stock's 52-week low/high is $0.004/$0.027.
- Green Growth Brands Announces Updated Terms Related To Its Acquisition Of Florida-Based Spring Oaks
- 420 with CNW – Cannabis Flavonoids Could Trigger Another Medical Marijuana Revolution
- Green Growth Brands Announces Bought Deal Public Offering of Units
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) intends to acquire privately held, Toronto-based Truverra Inc. in a three-cornered amalgamation between Truverra, Supreme Cannabis and a wholly owned subsidiary of Supreme Cannabis. The transaction for 14.7 million common shares of Supreme Cannabis has a value of approximately C$20 million (http://nnw.fm/7MwPa).
Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”
Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.
In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.
“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”
The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.
Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.
7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.
Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.
Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.
To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.
Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.
Supreme Cannabis Company Inc. (OTC: SPRWF), closed Monday's trading session at $1.10, off by 1.7857%, on 486,269 volume with 451 trades. The average volume for the last 3 months is 316,987 and the stock's 52-week low/high is $0.00019/$0.694000005.
- Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Announces Plans to Acquire Truverra Inc.
- 420 with CNW – More than 100 Cannabis Businesses Ask Congress to Consider Social Equity During Legalization
- Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Expands Executive Team; Appoints New Chief Information Officer and VP of Talent
Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)
Global developer and provider of cellular communications systems Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF) today announced its receipt of an initial purchase order of $130,000 through a leading Saudi Arabian cellular operator to equip a single end-use customer’s fleet of emergency response vehicles with its UV350, an LTE all-in-one in-vehicle smartphone. To view the full press release, visit: http://nnw.fm/6frUe.
Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of Push-to-Talk Over Cellular ("PTT/PoC") systems for enterprise customers. The company specializes in connected vehicle products for professional fleets and markets its products under the Uniden® Cellular brand.
Since its inception in 2012, Siyata has amassed a customer base that includes cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.
Recognized by the Toronto Venture Stock Exchange in 2018 as a Venture Top 50 Company, Siyata aims to deliver the highest quality and most technologically advanced mobile communication devices for global corporate workforces, fleets, homes and buildings.
The company has long been an industry pioneer, delivering the world's first 3G connected vehicle device as well as the world's first 4G/LTE vehicle mounted smartphone for First Responders and commercial fleets and vehicles.
Siyata is headquartered in Montréal, Québec, Canada.
Siyata's suite of technology includes numerous PTT and legacy devices, as well as cellular boosters designed to improve cellular signals in corporate warehouses, government embassies, retirement home campuses, banks and manufacturing plants.
The company's flagship product, the Uniden UV350, is the world's first vehicle-mounted 4G/LTE smartphone with crystal clear quality, carrier grade PTT, voice, text, video and data applications built into a single device. Specifically designed for First Responder and commercial fleet vehicles, the UV350 runs on cellular LTE networks that provide nationwide and global coverage, replacing traditional single purpose two-way radios that require a monthly fee and limited network coverage.
The Uniden UV350 is currently available through Bell Mobility, Canada's largest LTE network and PTT community. Expanding its availability, Siyata is completing network approval with two North American Tier 1 operators to launch the UV350 in the U.S. in 2019.
CEO and Chairman Marc Seelenfreund is the founder of Siyata. He is also the founder of Siyata's parent company, Accel Telecom, an Israel-based company that specializes in importing and distributing innovative cellular and IP devices to fixed line operators and mobile providers within Israel. Prior to establishing Accel, Seelenfreund was a vice president at Sunrise Corporation in New York where he focused on financing publicly traded technology companies. Seelenfreund has a law degree from Bar Ilan University, is a board member at Israel's leading private university, and has served as an officer in the Israel Defense Forces.
Glenn Kennedy, vice president of sales, has over 25 years of sales experience in the telecommunications industry. Prior to joining Siyata in 2016, Kennedy managed sales nationally for Motorola Canada, HTC Communications Canada, and Sonim Technologies. He holds a bachelor's degree in honors business administration from the Richard Ivey School of Business at the University of Western Ontario.
CFO Gerald Bernstein, a professional chartered accountant, has spent 20 years focusing on private equity financing and tax efficient corporate structuring in multi-jurisdictional arenas. He holds a bachelor's degree of commerce as well as a graduate diploma in public accountancy from McGill University. Bernstein has been a member of the Canadian Institute of Chartered Accountants since 1987.
Gidi Bracha, Vice President of Technology, has served in this position since 2011 and spearheaded the development of both the Truckfone, Voyager and UV350. Bracha served in various key positions at Cellcom, Israel's leading cellular provider, including head of car mobility products and director of type approvals. Bracha served as an engineer technician in the Anti-Aircraft division of the Air Force in the Israel Defense Forces and holds a bachelor's degree in engineering and business management from the University of Derby.
Siyata Mobile Inc. (SYATF), closed Monday's trading session at $0.3422, off by 6.727%, on 51,665 volume with 13 trades. The average volume for the last 3 months is 60,730 and the stock's 52-week low/high is $0.0185/$0.059999998.
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) to Launch UV350 with Leading National Saudi Arabian Cellular Operator
- Siyata Mobile Launches Uniden UV350 Desktop Dispatch Unit for Instant Communication to In-Vehicle and Mobile Enterprise Workforce
- Siyata Mobile Receives $360,000 Purchase Order to Equip Taxis with CP250 All-in-One Communications Device
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Announces Pricing of IPO and Increases Offering Size
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) 420 with CNW – Senate Could Hold Hearings on Cannabis Banking Later this Month
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Flagship PharmHouse JV Licensed By Health Canada
- Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) 420 with CNW – NYC Council Passes Two Cannabis Reform Resolutions
- ChineseInvestors.com (CIIX) 420 with CNW – NYC Council Passes Two Cannabis Reform Resolutions
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) to Acquire 19.9% Equity Interest of Coastal Green, a BC-Based Cannabis Retailer
- City View Green Holdings Inc. (CSE: CVGR) Reports Debt Settlements, Further Transactions
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Cool Events Inc. (RNWR) Reports Strong Attendance at Signature Fun Runs
- Earth Science Tech, Inc. (ETST) Attributes Increases in Distribution, Demand for Upsurge in Revenues
- Endonovo Therapeutics (OTCQB: ENDV) SofPulse Safely Reduces Pain, Swelling
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) QuadSight(TM) Prototype Ordered by American Subsidiary of Leading Global Supplier
- Genprex Inc. (NASDAQ: GNPX) Provides Update on Lead Drug Candidate for Treatment of Non-Small Cell Lung Cancer
- Geyser Brands Inc. (TSX.V: GYSR) Appoints Seasoned Life Sciences Executive to Board of Directors
- Golden Developing Solutions, Inc. (DVLP) Announces Record Preliminary Revenues for Q2 2019
- Grapefruit Boulevard Investments Inc. (IGNG) Why Grapefruit Boulevard Investments Inc. Is ‘One to Watch’
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) Announces Bought Deal Public Offering of Units
- Green Hygienics Holdings Inc. (GRYN) Secures License for Processing Hemp in the State of North Carolina
- Hemptown USA - Advances Growth Strategy via Nutraceutical Manufacturing Facility Acquisition
- INmune Bio, Inc. (NASDAQ: INMB) Co-Founder and CEO Presents at 17th Annual Congress of International Drug Discovery Science & Technology 2019
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) Completes Acquisition of Zoots - Premium Cannabis-Infused Edibles and Infused Products
- Lexaria Bioscience Corp. (CSE: LXX)(OTC: LXRP) Agreement Increases Reach of Ingested Cannabis Absorption Technology
- Marijuana Company of America Inc. (MCOA) Continues to Build Steam in California’s Cannabis Marketplace
- MustGrow Biologics Corp (CSE: MGRO) Counters Use of Controversial Pesticides with Natural, Effective Biopesticides and Biofertilizers
- Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P) Acquires 49% Interest in Budding Cannabis Industry Disruptor
- Nightfood, Inc. (OTCQB: NGTF) to Present at VirtualInvestorConferences.com on August 1, 2019
- Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Signs New Agreement for Access to 60,000kg of CBD-rich Hemp
- ORHub Inc. (ORHB) Settles Litigation with Former Chief Financial Officer
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) President Issues Letter to Shareholders
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Achieves Key Milestone of Form 10 Registration Statement Effectiveness
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Debuts New Look for Cannabis Line
- Pressure BioSciences Inc. (PBIO) Announces First Sale of the BaroShear K45, A Revolutionary Water-Soluble CBD Manufacturing System
- QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Holds Favorable Position as Rising EV Market Boosts Lithium Demand Worldwide
- Sharing Services Global Corporation (SHRG) Capitalizing on New Direct-Selling Opportunities Driven by Changing Retail Industry
- SinglePoint, Inc. (SING) CEO Discusses Acquisition Sales Success, CBD Business and Merchant Services Progress on MoneyTV with Donald Baillargeon
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Launches Uniden UV350 Desktop Dispatch Unit for Instant Communication to In-Vehicle and Mobile Enterprise Workforce
- Spectrum Global Solutions, Inc. (SGSI) Evolving with Acquisition of German Energy Infrastructure Tech Company
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) Ideally Positioned in High-Growth Market
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) Breaks Ground for Its Direct Lithium Extraction Demonstration Plant
- Sugarmade, Inc. (SGMD) Announces Initial Investment in Hempistry and Completion of BZRTH Audit
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) 420 with CNW – More than 100 Cannabis Businesses Ask Congress to Consider Social Equity During Legalization
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Upholds Commitment to Quality amid CBD Shortage
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Continues Testing of TherOZap(TM) Technology Against the Zika Virus
- TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) 420 with CNW – Thousands Submit Comments Urging FDA to Allow CBD in Supplements and Foods
- Trxade Group Inc. (TRXD) Web Platform Protects Profit Margins, Cuts Negative Reimbursement Costs
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) 420 with CNW – Thousands Submit Comments Urging FDA to Allow CBD in Supplements and Foods
- VPR Brands, LP (VPRB) Featured in Exclusive NetworkNewsWire Broadcast
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) 420 with CNW – Study Looks at How Marijuana Extracts Can Kill Cancer Cells
- Willow Biosciences Inc. (CSE: WLLW) 420 with CNW – Michigan Caregivers Grow More than a Million Marijuana Plants
- Youngevity International, Inc. (NASDAQ: YGYI) 420 with CNW – Michigan Caregivers Grow More than a Million Marijuana Plants
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.